XML 41 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Financial Instruments and Fair Value (Tables)
12 Months Ended
Jan. 31, 2022
Investments All Other Investments [Abstract]  
Schedule of Available-for-Sale Securities at Fair Value All of the investments are classified as available-for-sale securities and reported at fair value in the consolidated balance sheets. By the end of the third quarter of fiscal year 2022, the Company fully liquidated all of the investments and reported the remaining cash equivalents as follows:

 

 

 

As of January 31, 2022

 

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Fair Value

 

 

 

(in thousands)

 

Money market funds

 

$

20

 

 

$

 

 

$

 

 

$

20

 

Commercial paper

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds

 

 

 

 

 

 

 

 

 

 

 

 

Asset-backed securities

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

 

 

 

 

 

 

 

 

 

 

 

 

Total cash equivalents and marketable debt securities

 

$

20

 

 

$

 

 

$

 

 

$

20

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of January 31, 2021

 

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Fair Value

 

 

 

(in thousands)

 

Money market funds

 

$

171

 

 

$

 

 

$

 

 

$

171

 

Commercial paper

 

 

66,181

 

 

 

 

 

 

 

 

 

66,181

 

Corporate bonds

 

 

102,108

 

 

 

980

 

 

 

(7

)

 

 

103,081

 

Asset-backed securities

 

 

15,740

 

 

 

164

 

 

 

 

 

 

15,904

 

U.S. government securities

 

 

29,383

 

 

 

82

 

 

 

 

 

 

29,465

 

Total cash equivalents and marketable debt securities

 

$

213,583

 

 

$

1,226

 

 

$

(7

)

 

$

214,802

 

Schedule of Cash Equivalents and Marketable Debt Securities

 

     

 

 

As of

 

 

 

January 31, 2022

 

 

January 31, 2021

 

 

 

(in thousands)

 

Included in cash equivalents

 

$

20

 

 

$

15,368

 

Included in marketable debt securities

 

 

 

 

 

199,434

 

Total cash equivalents and marketable debt securities

 

$

20

 

 

$

214,802

 

Summary of Contractual Maturities of Investments

The contractual maturities of the investments at January 31, 2022 and 2021 were as follows:

 

 

 

As of

 

 

 

January 31, 2022

 

 

January 31, 2021

 

 

 

(in thousands)

 

Due within one year

 

$

20

 

 

$

135,899

 

Due within one to three years

 

 

 

 

 

78,903

 

Total cash equivalents and marketable debt securities

 

$

20

 

 

$

214,802

 

Schedule of Fair Value of Financial Instruments Measured on Recurring Basis

The following tables present the fair value of the financial instruments measured on a recurring basis as of January 31, 2022 and 2021, respectively:

 

 

 

As of January 31, 2022

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

 

(in thousands)

 

Money market funds

 

$

20

 

 

$

20

 

 

$

 

 

$

 

Commercial paper

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds

 

 

 

 

 

 

 

 

 

 

 

 

Asset-backed securities

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

 

 

 

 

 

 

 

 

 

 

 

 

Total cash equivalents and marketable debt securities

 

$

20

 

 

$

20

 

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of January 31, 2021

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

 

(in thousands)

 

Money market funds

 

$

171

 

 

$

171

 

 

$

 

 

$

 

Commercial paper

 

 

66,181

 

 

 

 

 

 

66,181

 

 

 

 

Corporate bonds

 

 

103,081

 

 

 

 

 

 

103,081

 

 

 

 

Asset-backed securities

 

 

15,904

 

 

 

 

 

 

15,904

 

 

 

 

U.S. government securities

 

 

29,465

 

 

 

 

 

 

29,465

 

 

 

 

Total cash equivalents and marketable debt securities

 

$

214,802

 

 

$

171

 

 

$

214,631

 

 

$